The Cooper Companies, Inc. is a San Ramon-based organization that produces contact lenses and specializes in women’s health care. With a market cap of $14.8 billion, the company is set to unveil its fiscal Q3 earnings for 2025 on August 27, 2025. Analysts predict a profit of $1.06 per share, showing a 10.4% increase from the previous year. For the full year, analysts anticipate an EPS of $4.06, a 10% rise from the previous fiscal year. COO shares have decreased by 19.8% over the past 52 weeks, underperforming the S&P 500 Index and the Health Care Select Sector SPDR Fund. Despite a 14.6% drop in shares after better-than-expected Q2 results, COO reported a 6.3% revenue increase year-over-year and an adjusted EPS of $0.96, surpassing analyst estimates. Wall Street analysts have a “Moderate Buy” rating on COO stock, with a mean price target of $92.93, indicating a 25.9% upside potential from current levels.

Read more at Yahoo Finance: What to Expect From Cooper Companies’ Q3 2025 Earnings Report